Gene expression analyses in cynomolgus monkeys provides mechanistic insight into high-density lipoprotein-cholesterol reduction by androgens in primates

Endocrinology

Volumn 149, Issue 4, 2008, Pages 1551-1561

  Nantermet, Pascale ^a   Harada, Shun Ichi ^a   Liu, Yuan ^b   Cheng, Spring ^b   Johnson, Colena ^a   Yu, Yuanjiang ^a   Kimme, Donald ^a   Holder, Daniel ^a   Hodor, Paul ^b   Phillips, Robert ^b   Ray, William J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ROSETTA INPHARMATICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; APOLIPOPROTEIN C1; CHOLESTEROL 7ALPHA MONOOXYGENASE; DRUG VEHICLE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANDROGEN SYNTHESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE ACID SYNTHESIS; BODY COMPOSITION; CELL ADHESION; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYTOSKELETON; DNA MICROARRAY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; INTRAABDOMINAL FAT; LIPID METABOLISM; LIVER BIOPSY; MOLECULAR MECHANICS; MONKEY; MUSCLE MASS; NONHUMAN; PARTICLE SIZE; PRIMATE; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

ADIPOSE TISSUE; ANIMALS; BODY COMPOSITION; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIHYDROTESTOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LIVER; MACACA FASCICULARIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 41549111592     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1151     Document Type: Article

References (58)

1. Somboonporn W 2006 Testosterone therapy for postmenopausal women: efficacy and safety. Semin Reprod Med 24:115-124
2. Shabsigh R, Katz M, Yan G, Makhsida N 2005 Cardiovascular issues in hypogonadism and testosterone therapy. Am J Cardiol 96:67M-72M
3. Wu FC, von Eckardstein A 2003 Androgens and coronary artery disease. Endocr Rev 24:183-217
4. Chen RY, Wittert GA, Andrews GR 2006 Relative androgen deficiency in relation to obesity and metabolic status in older men. Diabetes Obes Metab 8:429-435
5. Lambrinoudaki I, Christodoulakos G, Rizos D, Economou E, Argeitis J, Vlachou S, Creatsa M, Kouskouni E, Botsis D 2006 Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women. Eur J Endocrinol 154:907-916
6. Braga-Basaria M, Muller DC, Carducci MA, Dobs AS, Basaria S 2006 Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy. Int J Impot Res 18:494-498
7. Xu T, Wang X, Hou S, Zhu J, Zhang X, Huang X 2002 Effect of surgical castration on risk factors for arteriosclerosis of patients with prostate cancer. Chin Med J (Engl) 115:1336-1340
8. Zitzmann M, Brune M, Kornmann B, Gromoll J, von Eckardstein S, von Eckardstein A, Nieschlag E 2001 The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocrinol Metab 86:4867-4873
9. Zitzmann M, Gromoll J, von Eckardstein A, Nieschlag E 2003 The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia 46:31-39
10. Hersberger M, Muntwyler J, Funke H, Marti-Jaun J, Schulte H, Assmann G, Luscher TF, von Eckardstein A 2005 The CAG repeat polymorphism in the androgen receptor gene is associated with HDL-cholesterol but not with coronary atherosclerosis or myocardial infarction. Clin Chem 51:1110-1115
11. Page ST, Kupelian V, Bremner WJ, McKinlay JB 2006 The androgen receptor gene CAG repeat polymorphism does not predict increased risk of heart disease: longitudinal results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 65:333-339
12. Choi BG, McLaughlin MA 2007 Why men's hearts break: cardiovascular effects of sex steroids. Endocrinol Metab Clin North Am 36:365-377
13. Rosano GM, Cornoldi A, Fini M 2005 Effects of androgens on the cardiovascular system. J Endocrinol Invest 28:32-38
14. Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C 1999 Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 84:813-819
15. Nathan L, Shi W, Dinh H, Mukherjee TK, Wang X, Lusis AJ, Chaudhuri G 2001 Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci USA 98:3589-3593
16. Malkin CJ, Pugh PJ, Jones RD, Jones TH, Channer KS 2003 Testosterone as a protective factor against atherosclerosis - immunomodulation and influence upon plaque development and stability. J Endocrinol 178:373-380
17. Grundy SM, Vega GL, Otvos JD, Rainwater DL, Cohen JC 1999 Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence. J Lipid Res 40:229-234
18. Berg G, Schreier L, Geloso G, Otero P, Nagelberg A, Levalle O 2002 Impact on lipoprotein profile after long-term testosterone replacement in hypogonadal men. Horm Metab Res 34:87-92
19. Bausserman LL, Saritelli AL, Herbert PN 1997 Effects of short-term stanozolol administration on serum lipoproteins in hepatic lipase deficiency. Metabolism 46:992-996
20. Dickerman RD, McConathy WJ, Zachariah NY 1997 Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk. J Cardiovasc Risk 4:363-366
21. De Pergola G 2000 The adipose tissue metabolism: role of testosterone and dehydroepiandrosterone. Int J Obes Relat Metab Disord 24(Suppl 2):S59-S63
22. Weingand KW 1989 Atherosclerosis research in cynomolgus monkeys (Macaca fascicularis). Exp Mol Pathol 50:1-15
23. Clarkson TB, Adams MR, Kaplan JR, Koritnik DR 1984 Psychosocial and reproductive influences on plasma lipids, lipoproteins, and atherosclerosis in nonhuman primates. J Lipid Res 25:1629-1634
24. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH 2002 Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536
25. Tan KC, Shiu SW, Kung AW 1999 Alterations in hepatic lipase and lipoprotein subfractions with transdermal testosterone replacement therapy. Clin Endocrinol (Oxf) 51:765-769
26. Herbst KL, Amory JK, Brunzell JD, Chansky HA, Bremner WJ 2003 Testosterone administration to men increases hepatic lipase activity and decreases HDL and LDL size in 3 wk. Am J Physiol Endocrinol Metab 284:E1112-E1118
27. Borski RJ, Tsai W, DeMott-Friberg R, Barkan AL 1996 Regulation of somatic growth and the somatotropic axis by gonadal steroids: primary effect on insulin-like growth factor I gene expression and secretion. Endocrinology 137:3253-3259
28. Bavner A, Sanyal S, Gustafsson JA, Treuter E 2005 Transcriptional corepression by SHP: molecular mechanisms and physiological consequences. Trends Endocrinol Metab 16:478-488
29. Beigneux A, Hofmann AF, Young SG 2002 Human CYP7A1 deficiency: progress and enigmas. J Clin Invest 110:29-31
30. Dieudonne MN, Pecquery R, Boumediene A, Leneveu MC, Giudicelli Y 1998 Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am J Physiol 274:C1645-C1652
31. Zang H, Ryden M, Wahlen K, Dahlman-Wright K, Arner P, Linden Hirschberg A 2007 Effects of testosterone and estrogen treatment on lipolysis signaling pathways in subcutaneous adipose tissue of postmenopausal women. Fertil Steril 88:100-106
32. Anderson LA, McTernan PG, Harte AL, Barnett AH, Kumar S 2002 The regulation of HSL and LPL expression by DHT and flutamide in human subcutaneous adipose tissue. Diabetes Obes Metab 4:209-213
33. Bluher S, Kratzsch J, Kiess W 2005 Insulin-like growth factor I, growth hormone and insulin in white adipose tissue. Best Pract Res Clin Endocrinol Metab 19:577-587
34. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, Mac-Dougald OA 2000 Inhibition of adipogenesis by Wnt signaling. Science 289:950-953
35. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB 2005 Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436:356-362
36. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB 2006 Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354:2552-2563
37. Eckardstein A, Wu FC 2003 Testosterone and atherosclerosis. Growth Horm IGF Res 13(Suppl A):S72-S84
38. Grunfeld C, Kotler DP, Dobs A, Glesby M, Bhasin S 2006 Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study. J Acquir Immune Defic Syndr 41:304-314
39. Szeplaki G, Varga L, Valentin S, Kleiber M, Karadi I, Romics L, Fust G, Farkas H 2005 Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. J Allergy Clin Immunol 115:864-869
40. Langer C, Gansz B, Goepfert C, Engel T, Uehara Y, von Dehn G, Jansen H, Assmann G, von Eckardstein A 2002 Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages. Biochem Biophys Res Commun 296:1051-1057
41. Goodwin B, Watson MA, Kim H, Miao J, Kemper JK, Kliewer SA 2003 Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-α. Mol Endocrinol 17:386-394
42. Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, Verhagen A, Rivera CR, Mulvihill SJ, Malloy MJ, Kane JP 2002 Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 110:109-117
43. Wang S, Lai K, Moy FJ, Bhat A, Hartman HB, Evans MJ 2006 The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone. Endocrinology 147:4025-4033
44. De Pergola G, Holmang A, Svedberg J, Giorgino R, Bjorntorp P 1990 Testosterone treatment of ovariectomized rats: effects on lipolysis regulation in adipocytes. Acta Endocrinol (Copenh) 123:61-66
45. Giudicelli Y, Dieudonne MN, Lacasa D, Pasquier YN, Pecquery R 1993 Modulation by sex hormones of the membranous transducing system regulating fatty acid mobilization in adipose tissue. Prostaglandins Leukot Essent Fatty Acids 48:91-100
46. Singh R, Artaza JN, Taylor WE, Braga M, Yuan X, Gonzalez-Cadavid NF, Bhasin S 2006 Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with β-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 147:141-154
47. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF, Bhasin S 2003 Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144:5081-5088
48. Fan W, Yanase T, Nomura M, Okabe T, Goto K, Sato T, Kawano H, Kato S, Nawata H 2005 Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54:1000-1008
49. Kennell JA, MacDougald OA 2005 Wnt signaling inhibits adipogenesis through β-catenin-dependent and -independent mechanisms. J Biol Chem 280:24004-24010
50. Jiang XC, Moulin P, Quinet E, Goldberg IJ, Yacoub LK, Agellon LB, Compton D, Schnitzer-Polokoff R, Tall AR 1991 Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J Biol Chem 266: 4631-4639
51. Quinet E, Tall A, Ramakrishnan R, Rudel L 1991 Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J Clin Invest 87:1559-1566
52. Zhou H, Li Z, Hojjati MR, Jang D, Beyer TP, Cao G, Tall AR, Jiang XC 2006 Adipose tissue-specific CETP expression in mice: impact on plasma lipoprotein metabolism. J Lipid Res 47:2011-2019
53. Harada LM, Amigo L, Cazita PM, Salerno AG, Rigotti AA, Quintao EC, Oliveira HC 2007 CETP expression enhances liver HDL-cholesteryl ester uptake but does not alter VLDL and biliary lipid secretion. Atherosclerosis 191:313-318
54. Gautier T, Masson D, Jong MC, Duverneuil L, Le Guern N, Deckert V, Pais de Barros JP, Dumont L, Bataille A, Zak Z, Jiang XC, Tall AR, Havekes LM, Lagrost L 2002 Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/ApoCI-knocked out mice. J Biol Chem 277:31354-31363
55. Bamba V, Rader DJ 2007 Obesity and atherogenic dyslipidemia. Gastroenterology 132:2181-2190
56. Salter AM, Fong BS, Jimenez J, Rotstein L, Angel A 1987 Regional variation in high-density lipoprotein binding to human adipocyte plasma membranes of massively obese subjects. Eur J Clin Invest 17:16-22
57. Avramoglu RK, Basciano H, Adeli K 2006 Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta 368:1-19
58. Ginsberg HN, Zhang YL, Hernandez-Ono A 2005 Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 36:232-240